Royal Philips is adding another remote-monitoring platform to its portfolio with its planned acquisition of Cardiologs. The Paris-based company uses ECG data to detect potential cardiac arrhythmias.

Three studies demonstrate how Philips MCOT wearable ambulatory monitoring ECG and proprietary AI models applied to ECG digital biomarkers can help to improve diagnosis, reduce readmissions, and lower ...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today highlighted how it integrates AI in cardiac ultrasound and across cardiac care to help ...

CAMBRIDGE, Mass. – Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, today announced a collaboration with Epic to integrate Philips’ suite of cardiac ambulatory monitoring and ...

CAMBRIDGE, Mass. — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the Philips ECG AI Marketplace, a platform that gives cardiac care teams ...

Philips receives 510(k) clearance from the FDA for its professional defibrillator (Tempus LS- Manual), now offering its remote monitor and defibrillator solution (Tempus ALS) to EMS customers in the U ...

No seven-year itch here: After spending the better part of a decade putting aside their differences to team up on the combination of their respective patient monitoring technologies, Philips and ...

Philips will now offer the largest cardiac care portfolio through Epic's Aura platform CAMBRIDGE, Mass. - Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, today announced a ...

Anumana's FDA-cleared LEF algorithm becomes first certified third-party solution available through Philips’ ECG ecosystem As clinicians become more comfortable using AI-powered tools, healthcare ...

Philips will now offer the largest cardiac care portfolio through Epic’s Aura platform CAMBRIDGE, Mass. – Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, today announced a ...